Verastem Inc
VSTMBuild a strategy around VSTM
Verastem Inc AI Insights
Informational only. Not investment advice.Snapshot
- Negative equity (-15.5M) with 89.5M debt - balance sheet impaired. Cash of 137.7M covers ~1 year at current -133M TTM burn rate.[Common Stockholders Equity]
- Revenue 62% 3Y CAGR (TTM 13.4M) but operating loss of -160M dwarfs sales. R&D spend of 104M is 7.8x revenue.[Total Revenue 3Y Growth TTM]
- P/S of 41x vs industry median 4.1x - trading at 10x premium despite negative margins and equity.[P/S Ratio]
Watch Triggers
- Cash and Equivalents: Falls below 75M or burn rate accelerates beyond -150M annually — Triggers forced dilutive financing at distressed terms
- Total Revenue TTM: Quarterly revenue exceeds 5M (20M annualized run rate) — Would signal commercial inflection reducing financing pressure
- Issuance of Capital Stock: Any equity raise announcement — Dilution magnitude determines equity value preservation
Bull Case
83% gross margin (TTM) shows product economics work if pipeline succeeds. Revenue grew 62% 3Y CAGR from low base - commercial traction emerging.
Working capital of 94M and current ratio of 2.6x (154M/60M) provides near-term operational flexibility for clinical execution.
Bear Case
Negative equity (-15.5M) and 89.5M debt create existential dilution risk. Any capital raise at 552M market cap severely dilutes shareholders.
FCF of -141M TTM exceeds cash of 138M. Without financing, operations cease within 12 months. 5Y revenue CAGR of -32% shows prior struggles.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage VSTM's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Binary catalyst: regulatory/clinical outcomes will determine survival within 12 months
- Cash runway of ~12 months at -133M annual burn
- R&D of 104M TTM signals late-stage pipeline investment
- Negative equity requires capital raise or partnership
Valuation Context
Caveats
Public Strategies Rankings
See how Verastem Inc ranks across different investment strategies.
Leverage VSTM's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
VSTM Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$497.98M | — | ||
$380.15M | — | ||
0.00 | — | ||
$30.91M | +209.1% | — | |
$-3.02 | — | ||
-550% | +599.2% | — | |
-678% | +628.8% | — | |
$-147.13M | — | ||
-1,480% | — | ||
Beta 5Y (Monthly) | unknown | — |
VSTM Dividend History
VSTM Stock Splits
VSTM SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
03/04/26 | 12/31/25 | Unknown | |
11/04/25 | 09/30/25 | 10-Q | |
08/07/25 | 06/30/25 | 10-Q | |
05/13/25 | 03/31/25 | 10-Q | |
03/20/25 | 12/31/24 | 10-K | |
11/06/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/09/24 | 03/31/24 | 10-Q | |
03/14/24 | 12/31/23 | 10-K | |
11/08/23 | 09/30/23 | 10-Q | |
08/08/23 | 06/30/23 | 10-Q | |
05/09/23 | 03/31/23 | 10-Q | |
03/14/23 | 12/31/22 | 10-K | |
11/03/22 | 09/30/22 | 10-Q | |
08/08/22 | 06/30/22 | 10-Q | |
05/09/22 | 03/31/22 | 10-Q | |
03/28/22 | 12/31/21 | 10-K | |
11/04/21 | 09/30/21 | 10-Q | |
08/02/21 | 06/30/21 | 10-Q | |
05/11/21 | 03/31/21 | 10-Q | |
03/18/21 | 12/31/20 | 10-K | |
11/09/20 | 09/30/20 | 10-Q | |
08/10/20 | 06/30/20 | 10-Q | |
05/07/20 | 03/31/20 | 10-Q | |
03/11/20 | 12/31/19 | 10-K | |
10/30/19 | 09/30/19 | 10-Q | |
08/01/19 | 06/30/19 | 10-Q | |
05/09/19 | 03/31/19 | 10-Q | |
03/12/19 | 12/31/18 | 10-K | |
11/07/18 | 09/30/18 | 10-Q | |
08/08/18 | 06/30/18 | 10-Q | |
05/03/18 | 03/31/18 | 10-Q | |
03/13/18 | 12/31/17 | 10-K | |
11/07/17 | 09/30/17 | 10-Q | |
08/08/17 | 06/30/17 | 10-Q | |
05/10/17 | 03/31/17 | 10-Q | |
03/23/17 | 12/31/16 | 10-K | |
11/07/16 | 09/30/16 | 10-Q | |
08/08/16 | 06/30/16 | 10-Q | |
05/09/16 | 03/31/16 | 10-Q | |
03/03/16 | 12/31/15 | 10-K | |
11/09/15 | 09/30/15 | 10-Q | |
08/10/15 | 06/30/15 | 10-Q | |
05/11/15 | 03/31/15 | 10-Q | |
03/10/15 | 12/31/14 | 10-K | |
10/30/14 | 09/30/14 | 10-Q | |
08/07/14 | 06/30/14 | 10-Q | |
05/08/14 | 03/31/14 | 10-Q | |
03/06/14 | 12/31/13 | 10-K | |
11/12/13 | 09/30/13 | 10-Q | |
08/13/13 | 06/30/13 | 10-Q | |
05/09/13 | 03/31/13 | 10-Q | |
03/26/13 | 12/31/12 | 10-K | |
11/13/12 | 09/30/12 | 10-Q | |
08/13/12 | 06/30/12 | 10-Q | |
05/14/12 | 03/31/12 | 10-Q | |
03/30/12 | 12/31/11 | 10-K | |
01/27/12 | 09/30/11 | 424B4 | |
08/13/12 | 06/30/11 | 10-Q | |
05/14/12 | 03/31/11 | 10-Q |